European Medicines Agency Concludes On Use Of Celecoxib In Familial Adenomatous Polyposis

Links shared publicly online about this topic.

  • 279
    total visits

European Medicines Agency Concludes On Use Of Celecoxib In Familial Adenomatous Polyposis

medicalnewstoday.com —

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has finalised its review of the use of the COX-2 inhibitor celecoxib in the reduction of the number of adenoma

View full resource at medicalnewstoday.com

Tags: Osteoarthritis Medication, Rheumatoid Arthritis Medication, NSAIDs, COX-2 Inhibitor, Celebrex, Medical

  • Share

Most Recently Shared on May 20, 2011 at 4:05 pm By:

mnt_drugapprov MNT Drug Approvals

European Medicines Agency Concludes On Use Of Celecoxib In Familial Adenomatous Polyposis http://mnt.to/3W9g #regulatory

1 year ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Gastrointestinal MNT Gastrointestinal

Advertisement